Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

OBJECTIVE: To evaluate the efficacy and safety of two dosing regimens of fremanezumab in Japanese and Korean patients with episodic migraine. BACKGROUND: Episodic migraine, which accounts for more than 90% of migraine cases, is inadequately addressed by widely available preventive therapies. Fremane...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Fumihiko, Suzuki, Norihiro, Kim, Byung‐Kun, Tatsuoka, Yoshihisa, Imai, Noboru, Ning, Xiaoping, Ishida, Miki, Nagano, Kaori, Iba, Katsuhiro, Kondo, Hiroyuki, Koga, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457233/
https://www.ncbi.nlm.nih.gov/pubmed/34323290
http://dx.doi.org/10.1111/head.14178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457233/
https://www.ncbi.nlm.nih.gov/pubmed/34323290
http://dx.doi.org/10.1111/head.14178

Ejemplares similares